Header Logo

Connection

Joel Block to Cyclooxygenase Inhibitors

Back to Details
This is a "connection" page, showing publications Joel Block has written about Cyclooxygenase Inhibitors.
Joel Block
Connection Strength
0.042
Cyclooxygenase Inhibitors
  1. The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis. Phase II Rofecoxib Rheumatoid Arthritis Study Group. Clin Ther. 1999 Oct; 21(10):1688-702.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.